Semaglutide is a GLP-1 medication used within certain physician-supervised weight management programs. The medication affects processes related to appetite and digestion, while treatment recommendations depend on individual health needs. A healthcare provider reviews medical history and weight management goals before discussing whether semaglutide fits an individualized treatment plan. Here is more information about how semaglutide can support your weight loss goals:
Understanding Semaglutide
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. Ozempic and Wegovy both contain semaglutide, although they have different FDA-approved uses and prescribing criteria. A healthcare provider evaluates medical history and individual health needs before discussing either medication.
Wegovy is prescribed for chronic weight management in eligible patients and is administered according to an individualized treatment plan. Semaglutide medications are given as injections in areas such as the abdomen, thigh, or upper arm. Patients receive instructions about medication use, nutrition, physical activity, and ongoing monitoring from their healthcare provider.
Supporting Appetite Regulation
Semaglutide affects processes related to appetite, digestion, and blood sugar regulation. The medication interacts with GLP-1 receptors involved in hunger and digestion, and it slows the movement of food through the stomach. Semaglutide also affects insulin release and other processes involved in blood sugar management. A healthcare provider evaluates individual health needs and discusses how these effects relate to the patient’s prescribed treatment plan.
Addressing Overall Health
Semaglutide medications have different approved uses based on the specific prescription and individual patient needs. Wegovy is used for chronic weight management in eligible patients, while treatment includes ongoing monitoring of weight and other relevant health information. A healthcare provider reviews these factors throughout treatment and discusses changes based on individual findings.
Ozempic is prescribed for certain adults with Type 2 diabetes and has additional FDA-approved indications for specific patient populations. Providers monitor blood sugar and other relevant health factors as part of an individualized treatment plan. Treatment responses vary, so follow-up appointments allow the provider to evaluate progress and adjust recommendations when appropriate.
Identifying Treatment Candidates
Semaglutide treatment depends on the specific medication, prescribing criteria, medical history, and individual health needs. A healthcare provider evaluates each patient before discussing whether a GLP-1 medication fits the treatment plan. Factors reviewed during an evaluation may include:
- Reviewing body weight: Providers evaluate weight and other measurements within the broader health assessment.
- Reviewing medical conditions: Type 2 diabetes and weight-related conditions may influence medication recommendations.
- Reviewing treatment history: Providers discuss previous nutrition, physical activity, and weight management approaches.
- Reviewing health information: Medical history and current health factors guide discussions about available medications.
Semaglutide requires a prescription and ongoing medical supervision. A healthcare provider monitors treatment response, discusses side effects, and reviews progress during follow-up appointments. Treatment recommendations may change based on individual findings and the patient’s response to medication.
Preparing for Possible Side Effects
Some patients experience gastrointestinal side effects from semaglutide, including nausea, vomiting, constipation, and diarrhea. A healthcare provider explains possible side effects before treatment and monitors the patient’s response during follow-up appointments. The provider is able to adjust the medication dosage or treatment recommendations based on individual needs and reported symptoms. Patients can also discuss medication use, nutrition, physical activity, and other parts of their weight management plan with their provider.
Schedule Your Consultation Today
Semaglutide is able to form part of a physician-supervised weight management plan for eligible patients. A healthcare provider evaluates medical history, current health, and weight management goals before recommending treatment. The provider may combine medication with nutrition, physical activity, and other lifestyle recommendations based on individual needs. Schedule a weight management evaluation today to discuss whether semaglutide fits your treatment plan.